Half-life estimate, not bloodwork or dosing advice. Disclaimer.
200 mg twice a week for 12 weeks. With a 4.5d half-life, it levels off around day 24.5. The row runs longer than that, so the plateau is on the chart. Between doses it runs from about 274 to 346 mg, a swing of 21%. Each dose is a hump, and the floor stays up. After the last dose, the tail takes about 25 days to fall to a few percent.
Pedplot does not sell or help anyone obtain a compound, and it does not say what to take. Disclaimer · How the model works
Each page opens the plotter with that compound loaded. The steroid half-life table compares all 37 listed compounds.
The formulas are on How the model works; each compound page lists its sources.
An estimate of how much of each compound is still active, day by day, for the doses entered. Pedplot draws it from each compound's half-life and time to peak and adds every dose together. It is a model, not a blood test.
Turning milligrams into a blood concentration needs each compound's volume of distribution, and the model does not include one. So the line stays in remaining active mg (IU for compounds dosed in IU), after the ester weight is taken out.
Each compound carries a data-quality rating from its sources. Of the 37 listed, 9 are rated high (a drug label for that product and route), 7 medium (a human study or a partial label) and 21 low (community figures or sources that disagree). The curve is an average, and real levels vary from person to person. The steroid half-life table shows the rating for each compound.
Yes. Type the drug or brand name in the compound field. The catalog has 7 GLP-1s, with half-lives from 13 hours (Saxenda) to 18 days (Mazdu); Ozempic is 7 days and Mounjaro 5 days. They plot on the same chart as everything else.